[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia, Inc. (PHR) filing of Form 144 reports a proposed sale of 4,183 common shares to be sold through Fidelity Brokerage Services on 09/16/2025 with an aggregate market value of $97,398.65. The shares were acquired on 09/11/2025 via restricted stock vesting and were paid as compensation. The filer, identified in prior sales as Balaji Gandhi, sold 886 shares on 07/17/2025 for $23,820.82 and 9,583 shares on 08/25/2025 for $287,550.07. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

• Full compliance with Rule 144 disclosure: broker, dates, share counts, and aggregate market value are provided
• Shares acquired via restricted stock vesting, indicating compensation-related issuance rather than new external purchase

Negative

• None.

Insights

Securities Analyst

TL;DR: Officer/director filed to sell recently vested restricted shares worth ~$97K; prior sales this quarter totaled ~10.5K shares.

This Form 144 notifies a proposed sale of 4,183 common shares received through restricted stock vesting and identified as compensation. The execution venue is Fidelity on the NYSE on 09/16/2025. The filing also discloses two prior dispositions by the same person this quarter totaling 10,469 shares generating gross proceeds of $311,370.89. For investors, this is an insider liquidity event reflecting planned disposition of vested compensation, not an explicit statement about company fundamentals. The filing contains the routine attestation regarding absence of undisclosed material adverse information.

Corporate Governance Expert

TL;DR: Routine insider sale notice for vested compensation; disclosure appears complete for Rule 144 requirements.

The Form 144 shows acquisition by restricted stock vesting and sale planned via a broker, which aligns with common executive compensation and trading compliance. The filing names the broker and provides dates, share counts, and aggregate values required by the rule. There is no allegation of undisclosed material information; the signer makes the standard legal representation. This document is procedural and does not, on its face, indicate governance irregularities.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4183	97398.65	59914473	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/11/2025	Restricted Stock Vesting	Issuer			4183	09/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Balaji Gandhi 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	886	23820.82
Balaji Gandhi 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/25/2025	9583	287550.07

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Phreesia (PHR) Form 144 filed on 09/16/2025 report?

The filing reports a proposed sale of 4,183 common shares to be sold on 09/16/2025 via Fidelity with an aggregate market value of $97,398.65.

How were the 4,183 Phreesia shares acquired according to the filing?

They were acquired on 09/11/2025 through restricted stock vesting and the consideration is listed as compensation.

Has the filer sold other Phreesia shares recently?

Yes. The filer sold 886 shares on 07/17/2025 for $23,820.82 and 9,583 shares on 08/25/2025 for $287,550.07.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Fidelity Brokerage Services LLC located at the address listed in the filing.

Does the filing state whether the seller has undisclosed material information?

The filing includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.